|
Seton Hall Law Review Symposium
Preparing for a Pharmaceutical Response to Pandemic
Influenza Co-sponsored by the Health Law & Policy Program’s Center for Health & Pharmaceutical Law and the Gibbons Institute of Law, Science & Technology
October 23-24, 2008 -
Seton Hall Law School,
Newark, NJ |
- Funding Disclosure
- Directions & Accommodations
- About the Center for Health Law & Policy
- About the Gibbons Institute of Law, Science & Technology
Seton Hall Law School’s Center for Health and Pharmaceutical Law
and the SETON HALL LAW REVIEW will be hosting a symposium on
October 23-24, 2008, to examine the legal, ethical, and public
policy issues related to developing a pharmaceutical response to
an influenza pandemic. Panels will explore issues related to the
development and approval of vaccines and antiviral drugs, both
before and during a pandemic; the allocation of vaccines and
antiviral drugs in situations of scarcity; and issues related to
international equity.
The symposium will be held at Seton Hall Law School’s campus in
downtown Newark, New Jersey, which is a short walk from Newark
Penn Station and a short taxi ride from Newark International
Airport. The symposium will be widely publicized to academics,
government officials, pharmaceutical industry representatives,
and the public, and admission will be free. Papers from the
symposium will be published in a special issue of the SETON HALL
LAW REVIEW, which will be disseminated free of charge to a broad
group of stakeholders, including key government and industry
representatives.
The 2008 Seton Hall Law Review
Symposium, “Preparing for a Pharmaceutical Response to Pandemic
Influenza,” has been underwritten by a generous, unrestricted
gift from Roche.
